US Patent Issued to Viva Star Biosciences (Suzhou) on Oct. 27 for "Substituted tricyclic aza-heterocycles as SOS1 inhibitors" (Chinese, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,280, issued on Oct. 27, was assigned to Viva Star Biosciences (Suzhou) Co. Ltd. (Suzhou, China).

"Substituted tricyclic aza-heterocycles as SOS1 inhibitors" was invented by Hongjian Zhang (Plainsboro, N.J.), Jingjing Ji (Shanghai) and Peihua Sun (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to novel heterotricyclic compounds and analogues, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating a disease associated with mammalian RAS (Rat sarcoma virus) family proteins."

The patent was filed on March 1, 2022, under Application No. 18/280,175.

*For further informa...